113 related articles for article (PubMed ID: 8952517)
1. Cellular distribution of 92-kd type IV collagenase/gelatinase B in human hepatocellular carcinoma.
Ashida K; Nakatsukasa H; Higashi T; Ohguchi S; Hino N; Nouso K; Urabe Y; Yoshida K; Kinugasa N; Tsuji T
Am J Pathol; 1996 Dec; 149(6):1803-11. PubMed ID: 8952517
[TBL] [Abstract][Full Text] [Related]
2. Difference in gene expression for matrix metalloproteinase-1 between early and advanced hepatocellular carcinomas.
Okazaki I; Wada N; Nakano M; Saito A; Takasaki K; Doi M; Kameyama K; Otani Y; Kubochi K; Niioka M; Watanabe T; Maruyama K
Hepatology; 1997 Mar; 25(3):580-4. PubMed ID: 9049202
[TBL] [Abstract][Full Text] [Related]
3. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T
Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663
[TBL] [Abstract][Full Text] [Related]
4. Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas.
Nakatsukasa H; Ashida K; Higashi T; Ohguchi S; Tsuboi S; Hino N; Nouso K; Urabe Y; Kinugasa N; Yoshida K; Uematsu S; Ishizaki M; Kobayashi Y; Tsuji T
Hepatology; 1996 Jul; 24(1):82-8. PubMed ID: 8707287
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
Hayasaka A; Suzuki N; Fujimoto N; Iwama S; Fukuyama E; Kanda Y; Saisho H
Hepatology; 1996 Nov; 24(5):1058-62. PubMed ID: 8903375
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
7. Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma.
Le Bail B; Faouzi S; Boussarie L; Guirouilh J; Blanc JF; Carles J; Bioulac-Sage P; Balabaud C; Rosenbaum J
J Pathol; 1999 Sep; 189(1):46-52. PubMed ID: 10451487
[TBL] [Abstract][Full Text] [Related]
8. Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts.
Wucherpfennig AL; Li YP; Stetler-Stevenson WG; Rosenberg AE; Stashenko P
J Bone Miner Res; 1994 Apr; 9(4):549-56. PubMed ID: 8030443
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Määttä M; Soini Y; Liakka A; Autio-Harmainen H
Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver.
Nakamura K; Zen Y; Sato Y; Kozaka K; Matsui O; Harada K; Nakanuma Y
Hum Pathol; 2007 Oct; 38(10):1532-46. PubMed ID: 17640715
[TBL] [Abstract][Full Text] [Related]
11. Actual invasive potential of human hepatocellular carcinoma revealed by in situ gelatin zymography.
Kaneyoshi T; Nakatsukasa H; Higashi T; Fujiwara K; Naito I; Nouso K; Kariyama K; Kobayashi Y; Uemura M; Nakamura SI; Iwasaki Y; Tsuji T
Clin Cancer Res; 2001 Dec; 7(12):4027-32. PubMed ID: 11751497
[TBL] [Abstract][Full Text] [Related]
12. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin.
van den Oord JJ; Paemen L; Opdenakker G; de Wolf-Peeters C
Am J Pathol; 1997 Sep; 151(3):665-70. PubMed ID: 9284814
[TBL] [Abstract][Full Text] [Related]
13. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.
Forsyth PA; Wong H; Laing TD; Rewcastle NB; Morris DG; Muzik H; Leco KJ; Johnston RN; Brasher PM; Sutherland G; Edwards DR
Br J Cancer; 1999 Apr; 79(11-12):1828-35. PubMed ID: 10206300
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis.
Peng SY; Lai PL; Pan HW; Hsiao LP; Hsu HC
Oncol Rep; 2008 Apr; 19(4):1045-53. PubMed ID: 18357395
[TBL] [Abstract][Full Text] [Related]
15. Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma.
Dubuisson L; Monvoisin A; Nielsen BS; Le Bail B; Bioulac-Sage P; Rosenbaum J
J Pathol; 2000 Feb; 190(2):190-5. PubMed ID: 10657018
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer.
Nielsen BS; Sehested M; Kjeldsen L; Borregaard N; Rygaard J; Danø K
Lab Invest; 1997 Oct; 77(4):345-55. PubMed ID: 9354769
[TBL] [Abstract][Full Text] [Related]
17. Plasma matrix metalloproteinase-9 (gelatinase B) in patients with hepatocellular carcinoma.
Murawaki Y; Ikuta Y; Okamoto K; Mimura K; Koda M; Kawasaki H
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):351-7. PubMed ID: 11958288
[TBL] [Abstract][Full Text] [Related]
18. Expression of human macrophage metalloelastase gene in hepatocellular carcinoma: correlation with angiostatin generation and its clinical significance.
Gorrin Rivas MJ; Arii S; Furutani M; Harada T; Mizumoto M; Nishiyama H; Fujita J; Imamura M
Hepatology; 1998 Oct; 28(4):986-93. PubMed ID: 9755235
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasion.
Arai I; Nagano H; Kondo M; Yamamoto H; Hiraoka N; Sugita Y; Ota H; Yoshioka S; Nakamura M; Wada H; Damdinsuren B; Kato H; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshita K; Nakamori S; Wakasa K; Sakon M; Monden M
Hepatogastroenterology; 2007; 54(73):167-71. PubMed ID: 17419254
[TBL] [Abstract][Full Text] [Related]
20. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
